1690 related articles for article (PubMed ID: 20439549)
1. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
Sublette ME; Ellis SP; Geant AL; Mann JJ
J Clin Psychiatry; 2011 Dec; 72(12):1577-84. PubMed ID: 21939614
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
4. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
7. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
Rogers PJ; Appleton KM; Kessler D; Peters TJ; Gunnell D; Hayward RC; Heatherley SV; Christian LM; McNaughton SA; Ness AR
Br J Nutr; 2008 Feb; 99(2):421-31. PubMed ID: 17956647
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplements for preventing postnatal depression.
Miller BJ; Murray L; Beckmann MM; Kent T; Macfarlane B
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009104. PubMed ID: 24158923
[TBL] [Abstract][Full Text] [Related]
9. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
Puri BK; Martins JG
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
[TBL] [Abstract][Full Text] [Related]
10. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
Lin PY; Su KP
J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
[TBL] [Abstract][Full Text] [Related]
11. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W
Eur J Clin Nutr; 2018 Jun; 72(6):805-817. PubMed ID: 29284786
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
14. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial.
Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
J Am Coll Nutr; 2010 Feb; 29(1):55-64. PubMed ID: 20595646
[TBL] [Abstract][Full Text] [Related]
15. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
16. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
Miller PE; Van Elswyk M; Alexander DD
Am J Hypertens; 2014 Jul; 27(7):885-96. PubMed ID: 24610882
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.
Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J;
J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904
[TBL] [Abstract][Full Text] [Related]
18. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders.
Ciappolino V; Delvecchio G; Agostoni C; Mazzocchi A; Altamura AC; Brambilla P
J Affect Disord; 2017 Dec; 224():32-47. PubMed ID: 28089169
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.
Arnold LE; Young AS; Belury MA; Cole RM; Gracious B; Seidenfeld AM; Wolfson H; Fristad MA
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):223-233. PubMed ID: 28157380
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
